2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Myotonia: new trials by email Literature Review of Myotonia trials Research Report on Myotonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Global Study of Del-desiran for the Treatment of DM1 AOC 1001 (del-desiran), Placebo - DM1, Myotonic Dystrophy | Phase 3 | Completed | Avidity Biosciences, Inc. | 159 | 2024-05-30 | 2026-09-01 |
| Lamotrigine as Treatment of Myotonia Lamotrigine, Placebo - Dystrophia Myotonica Type 1, Myotonia Congenita | Phase 3 | Completed | Grete Andersen, MD | 27 | 2013-11-01 | 2016-04-25 |
Myotonic Disorders (2) · Myotonic Dystrophy (2) · Myotonia Congenita (1) · Paralysis, Hyperkalemic Periodic (1) · Potassium aggravated myotonia (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Heredodegenerative Disorders, Nervous System (2) · Muscular Diseases (2) · Muscular Disorders, Atrophic (2) · Muscular Dystrophies (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2) · Neurologic Manifestations (2) · Neuromuscular Diseases (2) · Neuromuscular Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Metabolic Diseases (1)
Lamotrigine (1)
Avidity Biosciences, Inc. (1) · Grete Andersen, MD (1)
Denmark (2) · Canada (1) · France (1) · Germany (1) · Italy (1) · Japan (1) · Netherlands (1) · Spain (1) · United Kingdom (1) · United States (1)